Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. STE
STE logo

STE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy STERIS plc (STE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
207.450
1 Day change
-2.92%
52 Week Range
269.440
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

STERIS plc (STE) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company shows strong financial growth, stable technical indicators, and a positive options sentiment. Despite no immediate trading signals or significant insider/hedge fund activity, the asset's fundamentals and growth potential make it a solid choice for long-term investment.

Technical Analysis

The MACD histogram is positive at 0.848, indicating bullish momentum, though it is contracting. RSI is neutral at 52.177, and moving averages are converging, suggesting no strong trend. The stock is trading near its pivot level of 223.125, with key resistance at 226.796 and support at 219.454.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
1

Positive Catalysts

  • Strong financial performance in Q3 2026 with revenue up 9.17% YoY, net income up 11.16% YoY, and EPS up 12.00% YoY. The company is a leader in infection prevention products, which is a stable and growing industry.

Neutral/Negative Catalysts

  • Gross margin decreased by 1.62% YoY, indicating slight pressure on profitability. No recent significant insider or hedge fund activity.

Financial Performance

In Q3 2026, revenue increased to $1.496 billion (up 9.17% YoY), net income rose to $192.9 million (up 11.16% YoY), and EPS grew to $1.96 (up 12.00% YoY). However, gross margin dropped to 43.81% (down 1.62% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent updates on analyst ratings or price target changes were provided.

Wall Street analysts forecast STE stock price to rise
Analyst Rating
0
Wall Street analysts forecast STE stock price to rise
Buy
Hold
Sell
0
Current: 213.700
sliders
Low
0
Averages
0
High
0
0
Current: 213.700
sliders
Low
0
Averages
0
High
0
Morgan Stanley
Ioannis Masvoulas
Equal Weight
maintain
AI Analysis
2026-01-08
Reason
Morgan Stanley
Ioannis Masvoulas
Price Target
AI Analysis
2026-01-08
maintain
Equal Weight
Reason
Morgan Stanley analyst Ioannis Masvoulas raised the firm's price target on Stora Enso to EUR 10.90 from EUR 10.70 and keeps an Equal Weight rating on the shares.
JPMorgan
Neutral
maintain
2025-12-05
Reason
JPMorgan
Price Target
2025-12-05
maintain
Neutral
Reason
JPMorgan raised the firm's price target on Stora Enso to EUR 10.50 from EUR 9.20 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for STE
Unlock Now

People Also Watch